[1] Ha YS,Kim WT,Yun SJ,et al.Multi-institutional analysis of localized renal cell carcinoma that demonstrates the impact of diabetic status on prognosis after nephrectomy[J].Ann Surg Oncol,2013,20(8):3662-3668.[2] Bella F,Minicozzi P,Giacomin A,et al.Impact of diabetes on overall and cancer-specific mortality in colorectal cancer patients [J].J Cancer Res Clin Oncol,2013,139(8):1303-1310.[3] Shau WY,Shao YY,Yeh YC,et al.Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinom[J].Oncologist,2012,17(6):856-862.[4] Luo J,Chen YJ,Chang LJ.Fasting blood glucose level and prognosis in non-small cell lung cancer (NSCLC) patients [J].Lung Cancer,2012,76(2):242-247.[5] Yamada K,Brink I,Engelhardt R.Factors influencing [F-18] 2-fluoro-2-deoxy-D-glucose (F-18 FDG) accumulation in melanoma cells: is FDG a substrate of multidrug resistance (MDR)? [J].J Dermatol,2005,32(5):335-345.[6] Higashi K,Ueda Y,Ikeda R,et al.P-glycoprotein expression is associated with FDG uptake and cell differentiation in patients with untreated lung cancer [J].Nucl Med Commun,2004,25(1):19-27.[7] Seo S,Hatano E,Higashi T,et al.Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation,P-glycoprotein expression,and outcome after resection in hepatocellular carcinoma[J].Clin Cancer Res,2007,13(2):427-433.[8] 郁春景,章 斌,邓胜明,等.P-gp影响18F-FDG摄取的体外实验 [J].中华核医学与分子影像杂志,2013,33(3):213-216.[9] Seo S,Hatano E,Higashi T,et al.Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis,P-glycoprotein expression,and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma[J].Surgery,2008,143(6):769-777.[10] Seo S,Hatano E,Higashi T,et al.P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro[J].Int J Oncol,2009,34(5):1303-1312.[11] Schott S,Schneeweiss A,Sohn C.Breast cancer and diabetes mellitus[J].Exp Clin Endocrinol Diabetes,2010,118(6):673-677.[12] Siegel EM,Ulrich CM,Poole EM,et al.The effects of obesity and obesity-related conditions on colorectal cancer prognosis[J].Cancer Control,2010,17(1):52-57.[13] Inal A,Kaplan MA,Kucukoner M,et al.Prognostic factors for second-line treatment of advanced non-small-cell lung cancer: retrospective analysis at a single institution[J].Asian Pac J Cancer Prev,2012,13(4):1281-1284.[14] Lee S,Hong SK,Kwak C,et al.Prognostic significance of diabetes mellitus in localized renal cell carcinoma [J].Jpn J Clin Oncol,2012,42(4):318-324.[15] Datema FR,Ferrier MB,van der Schroeff MP,et al.Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients [J].Head Neck,2010,32(6):728-736.[16] Louwman WJ,Janssen-Heijnen ML,Houterman S,et al.Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study[J].Eur J Cancer,2005,41(5):779-785. |